Dopamine Injection, Concentrate and Oxymorphone Extended-Release Tablets
Determining the interaction of Dopamine Injection, Concentrate and Oxymorphone Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dopamine
Brand name: Intropin
Synonyms: Dopamine Injection, DOPamine
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dopamine Injection, Concentrate-Oxymorphone Hydrochloride
- Dopamine Injection, Concentrate-Oxymorphone Injection
- Dopamine Injection, Concentrate-Oxymorphone Tablets
- Dopamine Injection, Concentrate-Oxytocin
- Dopamine Injection, Concentrate-Oxytocin Intravenous, Intramuscular
- Dopamine Injection, Concentrate-Oxytrol
- Oxymorphone Extended-Release Tablets-Dopram
- Oxymorphone Extended-Release Tablets-Doptelet
- Oxymorphone Extended-Release Tablets-Doral
- Oxymorphone Extended-Release Tablets-Doral Tablets
- Oxymorphone Extended-Release Tablets-Doravirine
- Oxymorphone Extended-Release Tablets-Doravirine, lamivudine, and tenofovir